Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.42 |
| ▸ | P2RX3 | P56373 | 3/20 | 0.42 |
| ▸ | P2RY6 | Q15077 | 2/20 | 0.38 |
| ▸ | POLG | P54098 | 1/20 | 0.37 |
| ▸ | P2RY2 | P41231 | 8/20 | 0.35 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.35 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.34 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 0.34 |
| ▸ | STING1 | Q86WV6 | 1/20 | 0.34 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.34 |
| ▸ | POLA1 | P09884 | 1/20 | 0.34 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.33 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31228213 | 0.85 | P2RY1 (0.46) | P2RX3P2RY2P2RY1P2RY11P2RX1 | |
| SCHEMBL31228386 | 0.83 | P2RY6 (0.43) | ADORA3P2RX3P2RY6P2RY2P2RY4 | |
| SCHEMBL23897672 | 0.82 | P2RY6 (0.47) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL31228133 | 0.81 | ADORA3 (0.36) | ADORA3P2RX3STING1 | |
| SCHEMBL23897725 | 0.80 | P2RY2 (0.45) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL23897774 | 0.80 | P2RY6 (0.48) | P2RY6P2RY2P2RY4 | |
| SCHEMBL23898226 | 0.79 | P2RY6 (0.45) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL23898281 | 0.78 | P2RY6 (0.42) | P2RY6P2RY2P2RY4POLA1 | |
| SCHEMBL31228108 | 0.78 | P2RY1 (0.45) | P2RX3P2RY2P2RY1P2RY11P2RX1 | |
| SCHEMBL21346151 | 0.77 | P2RY6 (0.47) | P2RY6P2RY2P2RY4POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |